The Beatrice Hunter Cancer Research Institute logo
  • Dr. Pollen K. Yeung, BSc Pharm, PhD

Appointments:

Professor, College of Pharmacy and Department of Medicine

Affiliations:

Dalhousie University

Research Interests:

Pharmacokinetics, Metabolism, Biomarkers, Cardiovascular Protection, Anti-cancer drugs

Although many anti-cancer drugs are highly effective against susceptible cancers in chemotherapy, they are often associated with serious cardiac adverse effects; and resistance to drug therapy may develop after prolonged treatment. It has been postulated that cardiac adverse effects may be reduced by combining them with drugs or natural health products for treatment of cardiovascular disease. Our research interest is to investigate whether or not combining these anti-cancer drugs with cardiovascular protective agents would improve pharmacokinetics and minimize their cardiovascular toxicities. This will lead to development of novel drug combinations of anti-cancer drugs for cancer chemotherapy, resulting in improved patient outcomes, longer survival and better quality of life.

Involvement with BHCRI to date:

Dr. Yeung is a BHCRI Associate Member and has served as a member of a BHCRI Scientific Review Committee.

Phone:

(902) 494-3845

Contact:

Pharmacokinetics and Metabolism Laboratory, College of Pharmacy, Dalhousie University, Halifax, NS, Canada B3H 4R2
Site by: Spectacle Group